How do German General Practitioners Manage Long-/Post-COVID? A Qualitative Study in Primary Care.
Beatrice E BachmeierSalome HölzleMohamed GasserMarjan van den AkkerPublished in: Viruses (2023)
Further research is required to develop and test pharmaceutical and non-pharmaceutical interventions for patients with Long-/Post-COVID. In addition, strategies to prevent the occurrence of Long-/Post-COVID after an acute infection with SARS-CoV-2 have to be developed. The routine collection of data on the diagnosis and management of Long-/Post-COVID may help in the formulation of best practices. It is up to policymakers to facilitate the necessary implementation of effective interventions in order to limit the huge societal consequences of large groups of patients suffering from Long-/Post-COVID.
Keyphrases
- sars cov
- coronavirus disease
- primary care
- respiratory syndrome coronavirus
- healthcare
- end stage renal disease
- newly diagnosed
- physical activity
- drug delivery
- prognostic factors
- peritoneal dialysis
- deep learning
- intensive care unit
- big data
- liver failure
- chronic kidney disease
- clinical practice
- hepatitis b virus
- machine learning
- quality improvement
- drug induced
- artificial intelligence